PFCS
Pale Fire Capital SE Portfolio holdings
AUM $958M
1-Year Return
80.1%
This Quarter Return
-0.82%
1 Year Return
+80.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$427M
AUM Growth
-$211M
(-33%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-40.71%
Top 10 Holdings %
Top 10 Hldgs %
94.19%
Holding
67
New
12
Increased
16
Reduced
16
Closed
16
Top Buys
| 1 |
B2Gold
BTG
|
+$86M |
| 2 |
uniQure
QURE
|
+$4.31M |
| 3 |
Aquestive Therapeutics
AQST
|
+$1.79M |
| 4 |
Shutterstock
SSTK
|
+$951K |
| 5 |
ATAI Life Sciences
ATAI
|
+$612K |
Top Sells
| 1 |
AT&T
T
|
+$211M |
| 2 |
Teladoc Health
TDOC
|
+$17.6M |
| 3 |
International Seaways
INSW
|
+$8.52M |
| 4 |
Praxis Precision Medicines
PRAX
|
+$4.92M |
| 5 |
Dole
DOLE
|
+$4.72M |
Sector Composition
| 1 | Materials | 34.18% |
| 2 | Communication Services | 31.68% |
| 3 | Consumer Staples | 19.66% |
| 4 | Healthcare | 6.51% |
| 5 | Energy | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Iovance Biotherapeutics
IOVA
$836M
| $288K | 0.07% |
38,875
+1,500
| +4% | +$11.1K |
|
|
27
Praxis Precision Medicines
PRAX
$941M
| $259K | 0.06% |
3,369
-63,915
| -95% | -$4.92M |
|
|
VERV
28
DELISTED
Verve Therapeutics
VERV
| $253K | 0.06% |
44,800
-800
| -2% | -$4.51K |
|
29
89bio
ETNB
$1.22B
| $238K | 0.05% |
+30,439
| New | +$238K |
|
30
Celcuity
CELC
$2.37B
| $229K | 0.05% |
17,458
| – | – |
|
31
Immatics
IMTX
$729M
| $224K | 0.05% |
31,462
+7,000
| +29% | +$49.8K |
|
32
Rezolute
RZLT
$675M
| $212K | 0.05% |
43,187
+18,898
| +78% | +$92.6K |
|
33
Biohaven
BHVN
$1.56B
| $205K | 0.05% |
5,496
| – | – |
|
34
Day One Biopharmaceuticals
DAWN
$730M
| $203K | 0.05% |
+16,006
| New | +$203K |
|
|
ADAM
35
Adamas Trust, Inc. Common Stock
ADAM
$670M
| $165K | 0.04% |
27,301
-180,670
| -87% | -$1.09M |
|
36
Achieve Life Sciences
ACHV
$155M
| $146K | 0.03% |
41,420
+8,301
| +25% | +$29.2K |
|
37
UroGen Pharma
URGN
$844M
| $133K | 0.03% |
+12,500
| New | +$133K |
|
38
TScan Therapeutics
TCRX
$96.5M
| $133K | 0.03% |
43,723
| – | – |
|
39
Larimar Therapeutics
LRMR
$353M
| $125K | 0.03% |
32,309
| – | – |
|
40
Indivior
INDV
$2.9B
| $124K | 0.03% |
+10,001
| New | +$124K |
|
41
Lexeo Therapeutics
LXEO
$281M
| $106K | 0.02% |
+16,100
| New | +$106K |
|
42
Nuvation Bio
NUVB
$1.13B
| $104K | 0.02% |
+39,000
| New | +$104K |
|
43
enGene Holdings
ENGN
$314M
| $97.8K | 0.02% |
+14,710
| New | +$97.8K |
|
44
Acrivon Therapeutics
ACRV
$51.3M
| $91.7K | 0.02% |
+15,235
| New | +$91.7K |
|
45
Regenxbio
RGNX
$473M
| $90.6K | 0.02% |
+11,721
| New | +$90.6K |
|
|
CMCT
46
Creative Media & Community Trust
CMCT
$5.65M
| $89.3K | 0.02% |
1,587
-359
| -18% | -$20.2K |
|
47
Sagimet Biosciences
SGMT
$206M
| $82.4K | 0.02% |
+18,310
| New | +$82.4K |
|
48
ASP Isotopes
ASPI
$815M
| $53K | 0.01% |
+11,700
| New | +$53K |
|
|
NEWP
49
New Pacific Metals
NEWP
$406M
| $49.7K | 0.01% |
42,130
+8,600
| +26% | +$10.1K |
|
|
ODV
50
Osisko Development Corp
ODV
$694M
| $46.4K | 0.01% |
28,491
+4,200
| +17% | +$6.85K |
|